Clinical Trials Insight: 700027408
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Plovamer (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 09 Sep 2009 Results have been presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
- 25 Aug 2009 Results will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, according to a Peptimmune media release.
- 25 Aug 2009 Status changed from recruiting to completed, as reported in a Peptimmune media release.